Blood-Based Biomarkers for Alzheimers and Parkinsons Disease
- 1st Edition, Volume 191 - December 1, 2026
- Latest edition
- Editor: Subashchandrabose Chinnathambi
- Language: English
Blood-Based Biomarkers for Alzheimer’s and Parkinson’s Disease, Volume 191 in the International Review of Neurobiology series, presents current advances and comprehensive r… Read more
Description
Description
Blood-Based Biomarkers for Alzheimer’s and Parkinson’s Disease, Volume 191 in the International Review of Neurobiology series, presents current advances and comprehensive reviews on the development and application of circulating biomarkers in neurodegenerative disorders. This volume brings together contributions from an international panel of experts, highlighting emerging strategies for early detection, diagnosis, and monitoring of Alzheimer’s and Parkinson’s diseases.
Chapters in this release explore a wide range of biomarker modalities, including exosomes, oxidative stress markers, mitochondrial dysfunction indicators, and astrocyte-associated proteins. Additional contributions examine advances in nanomaterial-based detection systems, proteomic approaches, and biofluid-based biosensors, as well as the role of neurofilament light chain and other circulating markers in clinical applications.
Further sections address the integration of biomarkers with disease mechanisms, including vascular contributions, microbiome influences, and metabolic and dietary factors. The volume also discusses challenges and opportunities in translating blood-based biomarkers into clinical practice. Together, these chapters provide a comprehensive overview of the evolving landscape of non-invasive biomarkers, making this volume an essential reference for researchers and clinicians in neuroscience and neurodegenerative disease research.
Key features
Key features
- Presents current advances in blood-based biomarkers for Alzheimer’s and Parkinson’s diseases
- Includes contributions from leading experts in neuroscience, biomarker research, and clinical neurobiology
- Covers diverse biomarker types including exosomes, proteomics, neurofilament light chain, and biosensors
- Explores emerging diagnostic technologies and clinical translation of non-invasive biomarkers
- Serves as an essential reference for researchers, clinicians, and graduate students
Readership
Readership
Table of contents
Table of contents
2. Blood Biomarkers of Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s and Parkinson’s Diseases
3. GFAP and the Genetic Code of Astrocyte Activation in Alzheimer’s Disease
4. Blood-Based Emerging Biomarkers in Early Detection and Diagnosis of Alzheimer’s Disease
5. Advances in Nanomaterial-Based Biomarker Detection for Neurodegenerative Diseases
6. Blood-Based Biomarkers in Alzheimer’s and Parkinson’s Disease: From Molecular Pathology to Therapeutic Potential
7. Blood-Based Biomarkers and Their Role in AD/PD Diagnosis
8. The Emerging Landscape of Circulatory Biomarkers in Alzheimer’s Disease
9. Biofluid-Based Biosensors
10. Biomarkers of Vascular Dementia and Alzheimer’s Disease
11. Silent Clues in Blood: Proteomic Approach for Alzheimer’s Disease
12. Blood-Based Biomarkers for Alzheimer’s Disease: Advances in Early Diagnosis and Clinical Translation
13. Microbiome, Epilepsy, and the Role of Probiotics in Mitigating Epilepsy
14. The Clinical Utility of Blood-Based Biomarkers of Alzheimer’s Disease: Triumphs and Pitfalls
15. Neurofilament Light Chain (NfL) as a Biomarker for Neurodegeneration: Protein Biology, Detection Methods, and Clinical Applications
16. Effect of Dietary Pattern on Biomarkers in Alzheimer’s Disease
17. Circulating Biochemical Signatures of Neurodegeneration in Alzheimer’s Disease
18. Peripheral Manifestations of Nigrostriatal Neurodegeneration in Parkinson’s Disease
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 191
- Published: December 1, 2026
- Language: English
About the editor
About the editor
SC
Subashchandrabose Chinnathambi
Subashchandrabose Chinnathambi is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau Cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, therapeutic approaches targeting Tau oligomers, and biomarkers for neurodegeneration. He serves on the editorial board for various international cell biology journals and is also a regular invited speaker at a number of meetings and workshops. Dr. Chinnathambi has more than 16 years of research experience in the area of neuroscience and Tau-related research in Alzheimer’s Disease.